KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.75 $7.64 Friday, 26th Apr 2024 FATE stock ended at $3.80. This is 1.81% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.47% from a day low at $3.75 to a day high of $3.95.
90 days $3.75 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Mar 07, 2016 $1.99 $2.18 $1.95 $2.14 363 300
Mar 04, 2016 $1.88 $2.23 $1.88 $1.97 1 319 000
Mar 03, 2016 $1.73 $1.85 $1.70 $1.83 303 200
Mar 02, 2016 $1.71 $1.75 $1.62 $1.70 184 900
Mar 01, 2016 $1.84 $1.84 $1.55 $1.69 288 100
Feb 29, 2016 $1.86 $1.86 $1.60 $1.76 469 800
Feb 26, 2016 $1.73 $1.84 $1.62 $1.83 576 800
Feb 25, 2016 $1.54 $1.71 $1.50 $1.69 947 800
Feb 24, 2016 $1.60 $1.60 $1.48 $1.51 269 700
Feb 23, 2016 $1.67 $1.67 $1.57 $1.62 122 800
Feb 22, 2016 $1.60 $1.70 $1.53 $1.67 307 900
Feb 19, 2016 $1.57 $1.64 $1.46 $1.55 319 800
Feb 18, 2016 $1.60 $1.87 $1.54 $1.56 971 700
Feb 17, 2016 $1.59 $1.65 $1.46 $1.57 1 718 700
Feb 16, 2016 $1.77 $1.79 $1.55 $1.57 957 000
Feb 12, 2016 $1.75 $1.80 $1.67 $1.69 122 100
Feb 11, 2016 $1.71 $1.90 $1.66 $1.68 155 200
Feb 10, 2016 $1.79 $1.92 $1.75 $1.77 94 100
Feb 09, 2016 $1.71 $1.85 $1.65 $1.80 111 800
Feb 08, 2016 $1.86 $1.88 $1.67 $1.69 125 300
Feb 05, 2016 $1.87 $1.97 $1.81 $1.90 88 000
Feb 04, 2016 $1.73 $2.01 $1.73 $1.90 255 200
Feb 03, 2016 $2.06 $2.09 $1.70 $1.75 720 400
Feb 02, 2016 $2.18 $2.21 $2.01 $2.05 127 400
Feb 01, 2016 $2.15 $2.25 $2.00 $2.22 135 400
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT